Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Ulrike Lorch, MD
Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C
This is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study of orally administered lomitapide in healthy male Japanese and C...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Ulrike Lorch, MD MFPM FRCA
Update Il y a 4 ans
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
This is a Phase I, double-blind, placebo-controlled, randomised within each dose group, single ascending dose study, with the objective to assess the safety, tolerability and pharmacokinet...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2